CORCEPT THERAPEUTICS INC Tax Withholding Paid on Stock Awards
CORCEPT THERAPEUTICS INC (CORT) reported Tax Withholding Paid on Stock Awards of $17.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $11.46M, a 7.80% decline year-over-year.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $5.76M, a 63.60% decline year-over-year.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $36.54M, a 423.09% increase year-over-year.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $8.15M, a 30.03% decline year-over-year.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for fiscal 2025 was $72.94M, a 227.08% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for fiscal 2024 was $22.30M, a 144.90% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for fiscal 2023 was $9.11M, a 57.97% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC payment, tax withholding, share-based payment arrangement for fiscal 2022 was $21.66M, a 5.12% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $17.22M 10-Q · filed 2026-07-29 | $53.76M derived: sum of 3 quarters · filed 2026-07-29 | $61.91M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $5.76M 10-Q · filed 2026-04-30 | $42.30M derived: sum of 2 quarters · filed 2026-04-30 | $50.45M derived: sum of 3 quarters · filed 2026-04-30 | $62.88M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $36.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $44.69M derived: sum of 2 quarters · filed 2026-02-24 | $57.12M derived: sum of 3 quarters · filed 2026-07-29 | $72.94M 10-K · filed 2026-02-24 |
| 2025-09-30 | $8.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $20.58M derived: sum of 2 quarters · filed 2026-07-29 | $36.40M 10-Q · filed 2025-11-04 | $43.39M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $12.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $28.25M 10-Q · filed 2026-07-29 | $35.24M derived: sum of 3 quarters · filed 2026-07-29 | $46.89M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $15.82M 10-Q · filed 2026-04-30 | $22.81M derived: sum of 2 quarters · filed 2026-04-30 | $34.46M derived: sum of 3 quarters · filed 2026-04-30 | $36.37M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $18.64M derived: sum of 2 quarters · filed 2026-02-24 | $20.55M derived: sum of 3 quarters · filed 2026-02-24 | $22.30M 10-K · filed 2026-02-24 |
| 2024-09-30 | $11.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $13.56M derived: sum of 2 quarters · filed 2025-11-04 | $15.32M 10-Q · filed 2025-11-04 | $16.31M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $3.67M 10-Q · filed 2025-07-31 | $4.66M derived: sum of 3 quarters · filed 2026-02-24 | $9.72M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.76M 10-Q · filed 2025-05-05 | $2.75M derived: sum of 2 quarters · filed 2026-02-24 | $7.81M derived: sum of 3 quarters · filed 2026-02-24 | $9.63M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $995.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.05M derived: sum of 2 quarters · filed 2026-02-24 | $7.88M derived: sum of 3 quarters · filed 2026-02-24 | $9.11M 10-K · filed 2026-02-24 |
| 2023-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $6.88M derived: sum of 2 quarters · filed 2024-10-30 | $8.11M 10-Q · filed 2024-10-30 | $8.96M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $3.05M 10-Q · filed 2024-07-29 | $3.90M derived: sum of 3 quarters · filed 2025-02-26 | $19.52M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.23M 10-Q · filed 2024-05-01 | $2.07M derived: sum of 2 quarters · filed 2025-02-26 | $17.70M derived: sum of 3 quarters · filed 2025-02-26 | $21.00M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $846.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $16.47M derived: sum of 2 quarters · filed 2025-02-26 | $19.78M derived: sum of 3 quarters · filed 2025-02-26 | $21.66M 10-K · filed 2025-02-26 |
| 2022-09-30 | $15.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $18.93M derived: sum of 2 quarters · filed 2023-11-01 | $20.82M 10-Q · filed 2023-11-01 | $23.34M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $5.19M 10-Q · filed 2023-08-02 | $7.71M derived: sum of 3 quarters · filed 2024-02-15 | $10.01M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $1.89M 10-Q · filed 2023-05-03 | $4.40M derived: sum of 2 quarters · filed 2024-02-15 | $6.70M derived: sum of 3 quarters · filed 2024-02-15 | $8.30M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $4.82M derived: sum of 2 quarters · filed 2024-02-15 | $6.42M derived: sum of 3 quarters · filed 2024-02-15 | $22.84M 10-K · filed 2024-02-15 |
| 2021-09-30 | $2.30M 10-Q · filed 2021-11-03 | $3.90M derived: sum of 2 quarters · filed 2021-11-03 | $20.32M 10-Q · filed 2022-11-03 | $21.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.60M 10-Q · filed 2021-07-29 | $18.05M 10-Q · filed 2022-08-04 | $19.02M derived: sum of 3 quarters · filed 2023-02-28 | $19.05M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $16.44M 10-Q · filed 2022-05-05 | $17.42M derived: sum of 2 quarters · filed 2023-02-28 | $17.45M derived: sum of 3 quarters · filed 2023-02-28 | $17.55M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $977.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.00M derived: sum of 2 quarters · filed 2023-02-28 | $1.10M derived: sum of 3 quarters · filed 2023-02-28 | $1.07M 10-K · filed 2023-02-28 |
| 2020-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $127.00K derived: sum of 2 quarters · filed 2021-11-03 | $90.00K 10-Q · filed 2021-11-03 | $2.05M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $100.00K 10-Q · filed 2021-07-29 | $63.00K 10-Q · filed 2021-07-29 | $2.02M derived: sum of 3 quarters · filed 2022-02-15 | $2.02M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $1.92M derived: sum of 2 quarters · filed 2022-02-15 | $1.92M derived: sum of 3 quarters · filed 2022-02-15 | $1.92M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.92M derived: sum of 2 quarters · filed 2022-02-15 | $1.92M derived: sum of 3 quarters · filed 2022-02-15 | $6.09M 10-K · filed 2022-02-15 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $0.00 derived: sum of 2 quarters · filed 2020-11-03 | $4.17M 10-Q · filed 2020-11-03 | $4.17M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $4.17M 10-Q · filed 2020-08-04 | $4.17M derived: sum of 3 quarters · filed 2021-02-23 | $4.17M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $4.17M 10-Q · filed 2020-05-04 | $4.17M derived: sum of 2 quarters · filed 2021-02-23 | $4.17M derived: sum of 3 quarters · filed 2021-02-23 | $4.17M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |